Will Palantir Crash?
AI and data analytics software major Palantir (NASDAQ:PLTR) has been…
Sell
41
CNA Quote, Financials, Valuation and Earnings
Last price:
$45.43
Seasonality move
:
0.13%
Day range:
$45.34 - $46.25
52-week range:
$43.11 - $52.36
Dividend yield:
3.96%
P/E ratio:
13.86x
P/S ratio:
0.87x
P/B ratio:
1.20x
Volume:
445.9K
Avg. volume:
307.7K
1-year change:
4.89%
Market cap:
$12.3B
Revenue:
$14B
EPS (TTM):
$3.28
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10.7B | $11.5B | $11.9B | $13.1B | $14B | |
| Revenue Growth (YoY) | -0.74% | 8.04% | 2.99% | 10.38% | 6.66% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $1.3B | $1.5B | $1.6B | $1.7B | $1.6B | |
| Operating Expenses | $2.3B | $2.5B | $2.8B | $2.9B | $3.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $122M | $113M | $112M | $127M | $133M | |
| EBT. Incl. Unusual Items | $821M | $1.5B | $814M | $1.5B | $1.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $131M | $278M | $132M | $313M | $252M | |
| Net Income to Company | $690M | $1.2B | $682M | $1.2B | $959M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $690M | $1.2B | $682M | $1.2B | $959M | |
| Basic EPS (Cont. Ops) | $2.54 | $4.36 | $2.51 | $4.44 | $3.53 | |
| Diluted EPS (Cont. Ops) | $2.53 | $4.34 | $2.51 | $4.43 | $3.52 | |
| Weighted Average Basic Share | $271.6M | $271.8M | $271.6M | $271.3M | $271.5M | |
| Weighted Average Diluted Share | $272.4M | $272.8M | $272.5M | $272.2M | $272.7M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $943M | $1.6B | $926M | $1.6B | $1.3B | |
| Revenue (Reported) | $10.7B | $11.5B | $11.9B | $13.1B | $14B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $943M | $1.6B | $926M | $1.6B | $1.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.8B | $2.9B | $3.1B | $3.4B | $3.6B | |
| Revenue Growth (YoY) | 23.22% | 1.56% | 9.07% | 8.41% | 5.34% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $343M | $389M | $414M | $416M | $406M | |
| Operating Expenses | $595M | $680M | $721M | $731M | $748M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $28M | $28M | $28M | $35M | $32M | |
| EBT. Incl. Unusual Items | $378M | $355M | $371M | $427M | $349M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $66M | $60M | $74M | $89M | $75M | |
| Net Income to Company | $312M | $295M | $297M | $338M | $274M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $312M | $295M | $297M | $338M | $274M | |
| Basic EPS (Cont. Ops) | $1.15 | $1.08 | $1.10 | $1.24 | $1.01 | |
| Diluted EPS (Cont. Ops) | $1.14 | $1.08 | $1.09 | $1.24 | $1.00 | |
| Weighted Average Basic Share | $271.9M | $271.8M | $271.3M | $271.6M | $271.3M | |
| Weighted Average Diluted Share | $272.9M | $272.9M | $272.3M | $272.7M | $272.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $406M | $383M | $399M | $462M | $381M | |
| Revenue (Reported) | $2.8B | $2.9B | $3.1B | $3.4B | $3.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $406M | $383M | $399M | $462M | $381M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $11.1B | $11.7B | $12.2B | $13.4B | $14.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $1.3B | $1.5B | $1.6B | $1.7B | $1.6B | |
| Operating Expenses | $2.3B | $2.6B | $2.9B | $3B | $3.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $119M | $113M | $112M | $134M | $130M | |
| EBT. Incl. Unusual Items | $1.3B | $1.4B | $830M | $1.6B | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $225M | $272M | $146M | $328M | $238M | |
| Net Income to Company | $1.1B | $1.2B | $684M | $1.2B | $895M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.1B | $1.2B | $684M | $1.2B | $895M | |
| Basic EPS (Cont. Ops) | $3.92 | $4.35 | $2.56 | $4.58 | $3.30 | |
| Diluted EPS (Cont. Ops) | $3.90 | $4.35 | $2.54 | $4.58 | $3.28 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $1.4B | $1.6B | $942M | $1.7B | $1.3B | |
| Revenue (Reported) | $11.1B | $11.7B | $12.2B | $13.4B | $14.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $1.4B | $1.6B | $942M | $1.7B | $1.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.8B | $2.9B | $3.1B | $3.4B | $3.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $343M | $389M | $414M | $416M | $406M | |
| Operating Expenses | $595M | $680M | $721M | $731M | $748M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $28M | $28M | $28M | $35M | $32M | |
| EBT. Incl. Unusual Items | $378M | $355M | $371M | $427M | $349M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $66M | $60M | $74M | $89M | $75M | |
| Net Income to Company | $312M | $295M | $297M | $338M | $274M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $312M | $295M | $297M | $338M | $274M | |
| Basic EPS (Cont. Ops) | $1.15 | $1.08 | $1.10 | $1.24 | $1.01 | |
| Diluted EPS (Cont. Ops) | $1.14 | $1.08 | $1.09 | $1.24 | $1.00 | |
| Weighted Average Basic Share | $271.9M | $271.8M | $271.3M | $271.6M | $271.3M | |
| Weighted Average Diluted Share | $272.9M | $272.9M | $272.3M | $272.7M | $272.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $406M | $383M | $399M | $462M | $381M | |
| Revenue (Reported) | $2.8B | $2.9B | $3.1B | $3.4B | $3.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $406M | $383M | $399M | $462M | $381M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $419M | $536M | $475M | $345M | $472M | |
| Short Term Investments | $1.9B | $2B | $39.5B | $2.2B | $2.1B | |
| Accounts Receivable, Net | $7.1B | $8.4B | $8.6B | $8.9B | $9.7B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $9.4B | $10.9B | $48.5B | $11.4B | $12.3B | |
| Property Plant And Equipment | $252M | $226M | $226M | $253M | $295M | |
| Long-Term Investments | $49.1B | $49.3B | $42.1B | $45.4B | $46.4B | |
| Goodwill | $148M | $148M | $144M | $146M | $145M | |
| Other Intangibles | $69M | $67M | $71M | $78M | $77M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $64B | $66.6B | $61B | $64.7B | $66.5B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | $550M | -- | |
| Long-Term Debt | $2.8B | $2.8B | $2.8B | $2.5B | $3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $51.3B | $53.8B | $52.5B | $54.8B | $56B | |
| Common Stock | $683M | $683M | $683M | $683M | $683M | |
| Other Common Equity Adj | $803M | $320M | -$3.6B | -$2.7B | -$2B | |
| Common Equity | $12.7B | $12.8B | $8.5B | $9.9B | $10.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $12.7B | $12.8B | $8.5B | $9.9B | $10.5B | |
| Total Liabilities and Equity | $64B | $66.6B | $61B | $64.7B | $66.5B | |
| Cash and Short Terms | $2.3B | $2.5B | $39.9B | $2.5B | $2.6B | |
| Total Debt | $2.8B | $2.8B | $2.8B | $3B | $3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $588M | $361M | $483M | $409M | $483M | |
| Short Term Investments | $1.3B | $1.3B | $40.3B | $3.2B | $3.4B | |
| Accounts Receivable, Net | $7.8B | $8.4B | $8.6B | $9B | $10B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $9.7B | $10.1B | $49.4B | $12.6B | $13.9B | |
| Property Plant And Equipment | $244M | $225M | $232M | $256M | $291M | |
| Long-Term Investments | $47.6B | $46.1B | $42.9B | $45.6B | $46.8B | |
| Goodwill | $148M | $147M | $145M | $146M | $146M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $63.7B | $63.8B | $62.1B | $65.1B | $67.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $243M | $550M | $500M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $243M | $550M | $500M | |
| Long-Term Debt | $2.8B | $2.8B | $2.5B | $3B | $2.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $51.6B | $53B | $53.4B | $55.4B | $57B | |
| Common Stock | $683M | $683M | $683M | $683M | $683M | |
| Other Common Equity Adj | $187M | -$1.3B | -$3.3B | -$2.6B | -$1.8B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $12.1B | $10.8B | $8.7B | $9.7B | $10.3B | |
| Total Liabilities and Equity | $63.7B | $63.8B | $62.1B | $65.1B | $67.3B | |
| Cash and Short Terms | $1.9B | $1.7B | $40.8B | $3.6B | $3.9B | |
| Total Debt | $2.8B | $2.8B | $2.8B | $3.5B | $3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $690M | $1.2B | $682M | $1.2B | $959M | |
| Depreciation & Amoritzation | $60M | $54M | $51M | $73M | $67M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$409M | -$1.4B | -$226M | -$245M | -$898M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.8B | $2B | $2.5B | $2.3B | $2.6B | |
| Capital Expenditures | $23M | $26M | $52M | $90M | $95M | |
| Cash Acquisitions | $149M | -$194M | -$199M | -$238M | -$238M | |
| Cash From Investing | -$705M | -$1.2B | -$1.5B | -$1.8B | -$1.3B | |
| Dividends Paid (Ex Special Dividend) | -$950M | -$621M | -$982M | -$787M | -$1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $495M | -- | -- | $491M | $490M | |
| Long-Term Debt Repaid | -$419M | -- | -- | -$243M | -$550M | |
| Repurchase of Common Stock | -$18M | -$18M | -$39M | -$24M | -$20M | |
| Other Financing Activities | -$10M | -$9M | -$11M | -$14M | -$12M | |
| Cash From Financing | -$902M | -$648M | -$1B | -$577M | -$1.1B | |
| Beginning Cash (CF) | $242M | $419M | $536M | $475M | $345M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $168M | $121M | -$42M | -$135M | $137M | |
| Ending Cash (CF) | $419M | $536M | $475M | $345M | $472M | |
| Levered Free Cash Flow | $1.8B | $2B | $2.5B | $2.2B | $2.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $312M | $295M | $297M | $338M | $274M | |
| Depreciation & Amoritzation | $14M | $13M | $12M | $16M | $17M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$700M | -$5M | -$24M | -$162M | -$221M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $82M | $645M | $436M | $504M | $638M | |
| Capital Expenditures | $3M | $12M | $20M | $20M | $18M | |
| Cash Acquisitions | -$12M | -$5M | -$88M | -$65M | -$53M | |
| Cash From Investing | $408M | -$129M | $51M | -$249M | $88M | |
| Dividends Paid (Ex Special Dividend) | -$310M | -$657M | -$445M | -$667M | -$673M | |
| Special Dividend Paid | $750K | $2M | $1.2M | $2M | $2M | |
| Long-Term Debt Issued | -- | -- | -- | $490M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$3M | -$21M | -$24M | -- | -$34M | |
| Other Financing Activities | -$8M | -$10M | -$11M | -$12M | -$15M | |
| Cash From Financing | -$321M | -$688M | -$480M | -$189M | -$722M | |
| Beginning Cash (CF) | $419M | $536M | $475M | $345M | $472M | |
| Foreign Exchange Rate Adjustment | -- | -$3M | $1M | -$2M | $7M | |
| Additions / Reductions | $169M | -$172M | $7M | $66M | $4M | |
| Ending Cash (CF) | $588M | $361M | $483M | $409M | $483M | |
| Levered Free Cash Flow | $79M | $633M | $416M | $484M | $620M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.1B | $1.2B | $684M | $1.2B | $895M | |
| Depreciation & Amoritzation | $58M | $53M | $50M | $77M | $68M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$880M | -$663M | -$245M | -$383M | -$957M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.6B | $2.6B | $2.3B | $2.4B | $2.7B | |
| Capital Expenditures | $23M | $35M | $60M | $90M | $93M | |
| Cash Acquisitions | -$35M | -$187M | -$282M | -$215M | -$226M | |
| Cash From Investing | -$1.4B | -$1.8B | -$1.3B | -$2.1B | -$980M | |
| Dividends Paid (Ex Special Dividend) | -$611M | -$968M | -$770M | -$1B | -$1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $981M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$3M | -$36M | -$42M | -- | -$54M | |
| Other Financing Activities | -$10M | -$11M | -$12M | -$15M | -$15M | |
| Cash From Financing | -$548M | -$1B | -$824M | -$286M | -$1.7B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$287M | -$220M | $137M | -$76M | $75M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.6B | $2.5B | $2.2B | $2.3B | $2.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $312M | $295M | $297M | $338M | $274M | |
| Depreciation & Amoritzation | $14M | $13M | $12M | $16M | $17M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$700M | -$5M | -$24M | -$162M | -$221M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $82M | $645M | $436M | $504M | $638M | |
| Capital Expenditures | $3M | $12M | $20M | $20M | $18M | |
| Cash Acquisitions | -$12M | -$5M | -$88M | -$65M | -$53M | |
| Cash From Investing | $408M | -$129M | $51M | -$249M | $88M | |
| Dividends Paid (Ex Special Dividend) | -$310M | -$657M | -$445M | -$667M | -$673M | |
| Special Dividend Paid | $750K | $2M | $1.2M | $2M | $2M | |
| Long-Term Debt Issued | -- | -- | -- | $490M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$3M | -$21M | -$24M | -- | -$34M | |
| Other Financing Activities | -$8M | -$10M | -$11M | -$12M | -$15M | |
| Cash From Financing | -$321M | -$688M | -$480M | -$189M | -$722M | |
| Beginning Cash (CF) | $419M | $536M | $475M | $345M | $472M | |
| Foreign Exchange Rate Adjustment | -- | -$3M | $1M | -$2M | $7M | |
| Additions / Reductions | $169M | -$172M | $7M | $66M | $4M | |
| Ending Cash (CF) | $588M | $361M | $483M | $409M | $483M | |
| Levered Free Cash Flow | $79M | $633M | $416M | $484M | $620M | |
Get CNA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CNA
Sector
P/E ratio
13.86x
11.67x
PEG ratio
0.51x
0.38x
P/B ratio
1.20x
1.05x
Price / LTM sales
0.87x
2.51x
Growth Metrics
CNA
Sector
Revenue growth
5.34%
5.1%
Earnings growth
-19.36%
2.87%
Revenue (5-year growth)
5.39%
5.19%
Earnings forecast
$1.03
$0.56
Profitability
CNA
Sector
Profitability FY 2025
--
$139.2M
Return on invested capital
6.73%
5.3%
Return on assets
1.35%
0.97%
Return on equity
8.76%
9.25%
Earnings Date
Last Earnings Date
May
5
Next Earnings Date
Jul
29
Estimated Next Earnings Date
Aug
4
Balance Sheet
CNA
Sector
Total cash
$3.9B
$467M
Short term investments
$2.1B
$233.6M
Total assets
$66.5B
$4B
Long term debt
$3B
$294.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Target’s Dividend Worth Buying?
Retail giant Target (NYSE:TGT) has been through an extremely volatile…
Where Will AST SpaceMobile Be In 5 Years?
Ever tried to send a text from the Nevada desert…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
37
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
49
RGC alert for Jun 17
Regencell Bioscience Holdings [RGC] is down 89.92% over the past day.
Buy
59
SYM alert for Jun 17
Symbotic [SYM] is up 16.02% over the past day.
Sell
43
TNXP alert for Jun 17
Tonix Pharmaceuticals Holding [TNXP] is up 15.6% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
